Ulf Meier-Kriesche
Technik-/Wissenschafts-/F&E-Leiter bei VELOXIS PHARMACEUTICALS A/S
Aktive Positionen von Ulf Meier-Kriesche
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VELOXIS PHARMACEUTICALS A/S | Technik-/Wissenschafts-/F&E-Leiter | 13.09.2017 | - |
Karriereverlauf von Ulf Meier-Kriesche
Ausbildung von Ulf Meier-Kriesche
University of Perugia | Doctorate Degree |
Statistik
International
Dänemark | 2 |
Italien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Börse
- Insiders
- Ulf Meier-Kriesche
- Erfahrung